blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3050561

EP3050561 - COMPOSITIONS OF CHLOROGENIC ACID AND METHODS FOR MAKING AND USING THE SAME IN OBESITY MANAGEMENT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.07.2021
Database last updated on 02.09.2024
FormerThe patent has been granted
Status updated on  14.08.2020
FormerGrant of patent is intended
Status updated on  22.04.2020
FormerExamination is in progress
Status updated on  22.06.2018
FormerRequest for examination was made
Status updated on  24.03.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Kodimule, Shyam Prasad
Plot No. 101
Jigani Industrial Area
2nd Phase
Anekal Taluk
562106 Bangalore / IN
For all designated states
Harakanahalli, Lingaraju Basavegowda
Plot No.101
Jigani Industrial Area
2nd Phase
Anekal Taluk
562106 Bangalore / IN
[2016/31]
Inventor(s)01 / see applicant
...
 [2016/31]
Representative(s)Banse, Klaus-Dieter
Banse & Steglich Patentanwälte PartmbB
Herzog-Heinrich-Straße 23
80336 München / DE
[2020/38]
Former [2016/31]Banse, Klaus-Dieter
Banse & Steglich
Patent- und Rechtsanwaltskanzlei
Herzog-Heinrich-Straße 23
80336 München / DE
Application number, filing date15179206.630.07.2015
[2016/31]
Priority number, dateUS201462031135P30.07.2014         Original published format: US 201462031135 P
[2016/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP3050561
Date:03.08.2016
Language:EN
[2016/31]
Type: A3 Search report 
No.:EP3050561
Date:14.09.2016
Language:EN
[2016/37]
Type: B1 Patent specification 
No.:EP3050561
Date:16.09.2020
Language:EN
[2020/38]
Search report(s)(Supplementary) European search report - dispatched on:EP17.08.2016
ClassificationIPC:A61K31/216, A61P3/04, A61K9/00, A61K36/74
[2016/37]
CPC:
A61K31/216 (EP,US); A61K36/74 (EP,US); A61K9/1271 (EP);
A61P3/04 (EP); A61K2236/00 (EP,US)
C-Set:
A61K31/216, A61K2300/00 (EP,US)
Former IPC [2016/31]A61K31/216, A61P3/04, A61K36/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/17]
Former [2016/31]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ZUSAMMENSETZUNGEN VON CHLOROGENSÄURE UND VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON IN DER ADIPOSITASVERWALTUNG[2016/31]
English:COMPOSITIONS OF CHLOROGENIC ACID AND METHODS FOR MAKING AND USING THE SAME IN OBESITY MANAGEMENT[2016/31]
French:COMPOSITIONS D'ACIDE CHLOROGÉNIQUE ET PROCÉDÉS POUR LES FABRIQUER ET LES UTILISER DANS LA GESTION DE L'OBÉSITÉ[2016/31]
Examination procedure30.07.2015Date on which the examining division has become responsible
14.03.2017Amendment by applicant (claims and/or description)
14.03.2017Examination requested  [2017/17]
21.06.2018Despatch of a communication from the examining division (Time limit: M06)
20.12.2018Reply to a communication from the examining division
07.05.2019Despatch of a communication from the examining division (Time limit: M04)
03.09.2019Reply to a communication from the examining division
23.04.2020Communication of intention to grant the patent
06.08.2020Fee for grant paid
06.08.2020Fee for publishing/printing paid
06.08.2020Receipt of the translation of the claim(s)
Opposition(s)17.06.2021No opposition filed within time limit [2021/34]
Fees paidRenewal fee
20.07.2017Renewal fee patent year 03
24.07.2018Renewal fee patent year 04
31.07.2019Renewal fee patent year 05
20.07.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.07.2015
AL16.09.2020
AT16.09.2020
CY16.09.2020
CZ16.09.2020
EE16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
MC16.09.2020
MK16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SE16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
[2024/22]
Former [2023/30]HU30.07.2015
AL16.09.2020
AT16.09.2020
CY16.09.2020
CZ16.09.2020
EE16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
MC16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SE16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
Former [2023/29]HU30.07.2015
AL16.09.2020
AT16.09.2020
CZ16.09.2020
EE16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
MC16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SE16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
Former [2022/18]AL16.09.2020
AT16.09.2020
CZ16.09.2020
EE16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
MC16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SE16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
Former [2021/36]AL16.09.2020
AT16.09.2020
CZ16.09.2020
EE16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SE16.09.2020
SI16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
Former [2021/28]AL16.09.2020
AT16.09.2020
CZ16.09.2020
EE16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SE16.09.2020
SK16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
Former [2021/25]AL16.09.2020
AT16.09.2020
CZ16.09.2020
EE16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
PL16.09.2020
RO16.09.2020
RS16.09.2020
SE16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
IS16.01.2021
PT18.01.2021
Former [2021/23]AT16.09.2020
CZ16.09.2020
EE16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
RO16.09.2020
RS16.09.2020
SE16.09.2020
SM16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
PT18.01.2021
Former [2021/22]CZ16.09.2020
EE16.09.2020
FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
RO16.09.2020
RS16.09.2020
SE16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
PT18.01.2021
Former [2021/21]FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
RS16.09.2020
SE16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
PT18.01.2021
Former [2021/20]FI16.09.2020
HR16.09.2020
LT16.09.2020
LV16.09.2020
RS16.09.2020
SE16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
Former [2021/10]FI16.09.2020
HR16.09.2020
LV16.09.2020
RS16.09.2020
SE16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
Former [2021/09]FI16.09.2020
SE16.09.2020
BG16.12.2020
NO16.12.2020
GR17.12.2020
Former [2021/08]FI16.09.2020
SE16.09.2020
BG16.12.2020
NO16.12.2020
Former [2021/07]FI16.09.2020
NO16.12.2020
Documents cited:Search[I]WO2006079056  (HOLT STEPHEN [US]) [I] 1-3,5,6 * the whole document * * page 2, line 23 - page 3, line 2 * * page 3, line 30 - page 4, line 21 * * page 5, line 27 - page 6, line 5 * * page 6, line 12 - line 14 * * page 7, line 3 - line 6 * * example 9 *;
 [I]  - T. MURASE ET AL, "Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice", AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM., US, (20101013), vol. 300, no. 1, doi:10.1152/ajpendo.00441.2010, ISSN 0193-1849, pages E122 - E133, XP055293184 [I] 1-3,5,6 * the whole document * * abstract * * page E122, column r, paragraph l - page E123, column l, paragraph 1 * * page E129, column l, paragraph 3 * * page E131, column r, paragraph l - page E132, column l, paragraph 1 *

DOI:   http://dx.doi.org/10.1152/ajpendo.00441.2010
 [I]  - ZHAO HUI ET AL, "Enrichment and Purification of Total Chlorogenic Acids from Tobacco Waste Extract with Macroporous Resins", SEPARATION SCIENCE AND TECHNOLOGY1993 NOV, (20100322), vol. 45, no. 6, doi:10.1080/01496390903566713, ISSN 0149-6395, pages 794 - 800, XP055293762 [I] 4 * the whole document * * abstract * * figure 1 * * "Analysis of T-CQAs by HPLC" and "preparation of Crude Extract"; page 796, column l * * page 800, column l, paragraph l *

DOI:   http://dx.doi.org/10.1080/01496390903566713
ExaminationUS2011223281
by applicant   - BROWN JP, "A review of the genetic effect of occurring flavonoids, anthraquinones and related compounds", MUTAT RES, (1980), vol. 75, no. 3, doi:doi:10.1016/0165-1110(80)90029-9, pages 243 - 277, XP023832571

DOI:   http://dx.doi.org/10.1016/0165-1110(80)90029-9
    - FARNSWORTH NR; AKERELE O; BINGEL AS; SOEJARTO DD; GUO Z, "Medicinal plants in therapy", BULL WORLD HEALTH ORGAN., (1985), vol. 63, no. 6, pages 965 - 81
    - JOVTCHEV G; STERGIOS M; SCHUBERT I, "A comparison of N-methyl- N-nitrosourea induced chromatid aberrations and micronuclei in barley meristems using FISH techniques", MUTAT RES, (2002), vol. 517, pages 47 - 51
    - KAMBOJ VP, "Herbal Medicine", CURR SC, (2000), vol. 78, no. 1, pages 35 - 37
    - SULTAN AO; CELIK TA, "Genotoxic and antimutagenic effects of Capparis spinosa L. on the Allium cepa L. root tip meristem cells", CARYOLOGIA, (2009), vol. 262, pages 114 - 123
    - SONG S. J.; CHOI S.; PARK T., "Decaffeinated Green Coffee Bean Extract Attenuates Diet-Induced Obesity and Insulin Resistance in Mice", EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, (2014), pages 1 - 14
    - VONGSAK B.; SITHISARN P.; GRITSANAPAN W., "Simultaneous Determination of Crypto-Chlorogenic Acid, Isoquercetin, and Astragalin Contents", MORINGA OLEIFERA LEAF EXTRACTS BY TLC-DENSITOMETRIC METHOD. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, (2013), pages 1 - 7
    - NARITA Y.; INOUYE K., "Degradation Kinetics of Chlorogenic Acid at Various pH Values and Effects of Ascorbic Acid and Epigallocatechin Gallate on Its Stability under Alkaline Conditions", J. AGRIC. FOOD CHEM., (2013), vol. 61, no. 4, pages 966 - 972
    - FARAH A.; PAULIS T. D.; MARTIN P. R.; TRUGO L. C., "Effect of Roasting on the Formation of Chlorogenic Acid Lactones in Coffee", J. AGRIC. FOOD CHEM., (2005), vol. 53, doi:doi:10.1021/JF048701T, pages 1505 - 1513, XP002527704

DOI:   http://dx.doi.org/10.1021/JF048701T
    - SAROJINI BK; VIDYAGAYATRI M; DARSHANRAJ CG; BHARATH BR; MANJUNATHA H, "DPPH scavenging assay of novel 1,3-disubstituted-1H-pyrazol-5-ols and their in silico studies on some proteins involved in Alzheimer's disease signaling cascade", LETTERS IN DRUG DESIGN & DISCOVERY, (2011), vol. 7, pages 214 - 224
    - BLOIS MS, "Antioxidant determinations by the use of a stable free radical", NATURE, (1958), vol. 26, pages 1199 - 1200
    - NISHIKIMI M; APPAJI N; YAGI K, "The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (1972), vol. 46, pages 849 - 854
    - OYAIZU M, "Studies on product of browning reaction prepared from glucose amine", JAPAN JOURNAL OF NUTRITION, (1986), vol. 44, pages 307 - 315
    - PRIETO P; PINEDA M; AGUILAR M, "Spectrophotometric quantitation of antioxidant capacity through the formation of a Phosphomolybdenum Complex: Specific application to the determination of vitamin E", ANALYTICAL BIOCHEMISTRY, (1999), vol. 269, pages 337 - 341
    - FRAYLING TM; TIMPSON NJ; WEEDON MN; ZEGGINI E; FREATHY RM; LINDGREN CM; PERRY JR; ELLIOTT KS; LANGO H; RAYNER NW, "A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity", SCIENCE, (2007), vol. 316, no. 5826, pages 889 - 94
    - MELNIKOVA I; WAGES D, "Antiobesity therapies", NATURE REVIEWS DRUG DISCOVERY, (2006), vol. 5, pages 369 - 370
    - RODRIGUEZ A; INFANTE D, "Characterization in silico of flavonoids biosynthesis in Theobroma cacao L", NETWORK BIOLOGY, (2011), vol. 1, pages 34 - 45
    - SHI Y; BURN P, "Lipid metabolic enzymes: emerging drug targets for the treatment of obesity", NATURE REVIEWS DRUG DISCOVERY, (2004), vol. 3, pages 695 - 710
    - SHOELSON SE; HERRERO L; NAAZ A, "Obesity, inflammation and insulin resistance", GASTROENTEROLOGY, (2007), vol. 132, no. 6, doi:doi:10.1053/j.gastro.2007.03.059, pages 2169 - 80, XP022072505

DOI:   http://dx.doi.org/10.1053/j.gastro.2007.03.059
    - STRADER CD; HWA JJ; VAN HEEK M; PARKER EM, "Novel molecular targets for the treatment of obesity", DRUG DISCOVERY TODAY, (1998), vol. 3, pages 250 - 256
    - CUDREY CH VAN TIBEURGH; GARGOURI Y; VERGER R, "Inactivation of pancreatic lipase by amphiphlic reagents 5-(dodecyldithio)-2-nitrobenzoic acid and tetrahydrolipstatin. Dependence upon partitioning between micllar and oil phases", BIOCHEMISTRY, (1993), vol. 32, pages 800 - 808
    - HADVARY P; LENGSFELD H; WOLFER H, "Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin", BIOCHEM. J., (1988), vol. 256, pages 357 - 361
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.